Based on recent data, Enlivex Therapeutics Ltd. (ENLV) shows an Average True Range (ATR) of 0.09 and an Enterprise Value of 27.99M. Its average trading volume over the past 3 months is 553.52K, indicating liquidity. These fundamental metrics provide insight into ENLV's underlying financial health and market activity.
| ATR | 0.09 |
| Enterprise Value | 27.99M |
| Avg Vol (3 Months) | 553.52K |
| Avg Vol (10 Days) | 365.76K |
Enlivex Therapeutics Ltd. (ENLV) technical indicators as of March 3, 2026: the SMA 20 is 4.69%, SMA 50 at 18.13%, and SMA 200 at 7.41%. The RSI 14 value is 57.6, suggesting its current momentum. These technical analysis signals help assess ENLV's price trends and potential future movements.
| SMA 20 | 4.69% |
| SMA 50 | 18.13% |
| SMA 200 | 7.41% |
| RSI 14 | 57.6 |
Enlivex Therapeutics Ltd. (ENLV) stock performance overview as of March 3, 2026: The 52-week high is $2.1 (currently -45.24% below), and the 52-week low is $0.66 (currently 74.24% above). Over the past year, ENLV's performance is -14.78%, compared to the S&P 500's 12.64% change.
| 52-Week High | 2.1 |
| 52-Week High Chg | -45.24% |
| 52-Week Low | 0.66 |
| 52-Week Low Chg | +74.24% |
| S&P 500 52-Week Chg | 12.64% |
According to market data, Enlivex Therapeutics Ltd. (ENLV) stock's recent performance metrics show that over the last month, ENLV is 17.52%, with a Year-to-Date (YTD) performance of 39.36%. Over the past year, the stock has seen a -14.78% change. These figures summarize ENLV's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.25 | 1.26 | 1.26 | 1.81 | 2.1 | 1.26 |
| Low | 1.03 | 0.99 | 0.66 | 0.66 | 0.66 | 0.7034 |
| Performance | +2.87% | +17.52% | -7.55% | -17.65% | -14.78% | +39.36% |
According to current financial data, ENLV stock's P/E (TTM) ratio is -2.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ENLV, including P/S (N/A), P/B (1.60), and P/FCF (-2.29), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ENLV | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.2 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 1.6 | -579.16 | 7.56 | 4.85 |
| P/FCF (TTM) | -2.29 | 9537.15 | -225.34 | 33.82 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep